Mofag-P Eye Drop is a combination of moxifloxacin and prednisolone, specifically designed to treat bacterial conjunctivitis and reduce inflammation. The 0.5% w/v moxifloxacin component provides antimicrobial activity against a wide range of bacteria, including Staphylococcus aureus, Streptococcus pneumoniae, and Haemophilus influenzae, while the 0.1% w/v prednisolone component contributes to anti-inflammatory and antiproliferative effects. The synergistic combination of these two active ingredients enables effective treatment of both the infective and inflammatory components of conjunctivitis. Mofag-P Eye Drop is suitable for use in patients with bacterial conjunctivitis, including those with a history of anterior uveitis, and is particularly useful in treating conditions where antimicrobial therapy is necessary, such as in patients with contact lens-related conjunctivitis. The product is available in a sterile, preserved-free, and isotonic solution, making it an effective and convenient treatment option for healthcare professionals and patients alike.